医学
射血分数
心肌梗塞
临床终点
安慰剂
人口
内科学
心脏病学
经皮冠状动脉介入治疗
临床试验
外科
心力衰竭
病理
环境卫生
替代医学
作者
Kai C. Wollert,Gerd Peter Meyer,Jochen Müller‐Ehmsen,Carsten Tschöpe,Vernon Bonarjee,Alf Inge Larsen,Andreas E. May,Klaus Empen,Emmanuel Chorianopoulos,Ulrich Tebbe,Johannes Waltenberger,Heiko Mahrholdt,Benedikta Ritter,Jens Pirr,Dieter Fischer,Mortimer Korf‐Klingebiel,Lubomir Arseniev,Hans‐Gert Heuft,Jan E. Brinchmann,Diethelm Messinger
标识
DOI:10.1093/eurheartj/ehx188
摘要
The BOOST-2 trial does not support the use of nucleated BMCs in patients with STEMI and moderately reduced LVEF treated according to current standards of early PCI and drug therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI